Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Salarius Pharmaceuticals Inc
SLRXCurrent price
1.75 USD
-0.03 USD (-1.69%)
Last closed
1.71 USD
Company
www.salariuspharma.com
ISIN
US79400X1072
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 248 209 USD
Yield for 12 month
-72.41 %
1Y
3Y
5Y
10Y
15Y
SLRX
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas. Address: 2450 Holcombe Boulevard, Houston, TX, United States, 77021
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
26 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-10 051 USD
Last Year
-6 677 USD
Current Quarter
-1 106 USD
Last Quarter
-1 107 USD
Key Figures SLRX
1 year
3 years
5 years
10 years
EBITDA
-6 733 092 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-53.99 %
PEG Ratio
–
Return On Equity TTM
-119.83 %
Wall Street Target Price
26 USD
Revenue TTM
–
Book Value
3.71 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-15 836 828 USD
Earnings per share
-8.73 USD
Diluted Eps TTM
-8.73 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SLRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SLRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
17.06.2024
Dividend Date
22.07.2019
Stock Valuation SLRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.1368
Price Sales TTM
18.1198
Enterprise Value EBITDA
1.5245
Price Book MRQ
0.9465
Financials SLRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SLRX
For 52 weeks
1.35 USD
7.6 USD
50 Day MA
2.06 USD
Shares Short Prior Month
42 520
200 Day MA
3.75 USD
Short Ratio
0.02
Shares Short
15 326
Short Percent
1.07 %
BeatStart